mfsQ encoding an MFS efflux pump mediates adaptive protection of Stenotrophomonas maltophilia against benzalkonium chloride. Chittrakanwong J, Charoenlap N, Mongkolsuk S, Vattanaviboon P. Can J Microbiol. 2021 Jun;67(6):491-495. doi: 10.1139/cjm-2020-0341. Epub 2020 Nov 5. PMID: 33151759

01 Jun 2021
0
0

mfsQ encoding an MFS efflux pump mediates adaptive protection of Stenotrophomonas maltophilia against benzalkonium chloride.
Chittrakanwong J, Charoenlap N, Mongkolsuk S, Vattanaviboon P.
Can J Microbiol. 2021 Jun;67(6):491-495. doi: 10.1139/cjm-2020-0341. Epub 2020 Nov 5.
PMID: 33151759

Tags

Share this

Related Posts

Disadee, W., Mahidol, C., Sahakitpichan, P., Sitthimonchai, S., Ruchirawat, S., & Kanchanapoom, T. (2011). Flavonol 3-O-robinobiosides and 3-O-(2″-O-α-rhamnopyranosyl)-robinobiosides from Sesuvium portulacastrum. Tetrahedron, 67(23), 4221-4226. https://doi.org/10.1016/j.tet.2011.04.041
10 Jun 2011
0

Disadee, W., Mahidol, C., Sahakitpichan, P., Sitthimonchai, S., Ruchirawat, S., & Kanchanapoom, T. (2011). Flavonol 3-O-robinobiosides and 3-O-(2″-O-α-rhamnopyranosyl)-robinobiosides from Sesuvium portulacastrum. Tetrahedron, 67(23), 4221-4226. https://doi.org/10.1016/j.tet.2011.04.041

Disadee, W., Mahidol, C., Sahakitpichan, P., Sitthimonchai, S., Ruchirawat, S., & Kanchanapoom, T. (2011). Flavonol 3-O-robinobiosides and 3-O-(2″-O-α-rhamnopyranosyl)-robinobiosides from Sesuvium portulacastrum. Tetrahedron, 67(23), 4221-4226. https://doi.org/10.1016/j.tet.2011.04.041
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
New
20 Sep 2023
0
New

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More